𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rivastigmine in Parkinson’s Disease Dementia

✍ Scribed by M. Asif A. Siddiqui, Antona J. Wagstaff

Book ID
120806010
Publisher
Springer International Publishing AG
Year
2007
Tongue
English
Weight
110 KB
Volume
24
Category
Article
ISSN
1170-229X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivastigmine versus placebo in hyperhomo
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients
✍ Paolo Barone; David J. Burn; Teus van Laar; Chuanchieh Hsu; Werner Poewe; Roger 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract The effects of rivastigmine versus placebo in Parkinson's disease dementia (PDD) patients with elevated or normal/low plasma homocysteine were determined. In this prospective analysis of a 24‐week, randomly assigned, placebo‐controlled study of rivastigmine in PDD, subpopulations compri